200 related articles for article (PubMed ID: 8346181)
1. HLA-DR expression in bile duct damage in hepatitis C.
Danque PO; Bach N; Schaffner F; Gerber MA; Thung SN
Mod Pathol; 1993 May; 6(3):327-32. PubMed ID: 8346181
[TBL] [Abstract][Full Text] [Related]
2. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies.
Kaji K; Nakanuma Y; Sasaki M; Unoura M; Kobayashi K; Nonomura A; Tsuneyama K; Van de Water J; Gershwin ME
Mod Pathol; 1994 Dec; 7(9):937-45. PubMed ID: 7892163
[TBL] [Abstract][Full Text] [Related]
3. Correspondence re: Pamela Danque et al. HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol 6:327, 1993.
Guido M
Mod Pathol; 1995 Apr; 8(3):341-2. PubMed ID: 7617662
[No Abstract] [Full Text] [Related]
4. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.
Ballardini G; Bianchi FB; Mirakian R; Fallani M; Pisi E; Bottazzo GF
Clin Exp Immunol; 1987 Oct; 70(1):35-46. PubMed ID: 3319302
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis.
Yasoshima M; Nakanuma Y; Tsuneyama K; Van de Water J; Gershwin ME
J Pathol; 1995 Mar; 175(3):319-25. PubMed ID: 7538164
[TBL] [Abstract][Full Text] [Related]
6. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
Hubscher SG; Adams DH; Elias E
J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
[TBL] [Abstract][Full Text] [Related]
7. A spectrum of histopathologic findings in autoimmune liver disease.
Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L
Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543
[TBL] [Abstract][Full Text] [Related]
8. The antigenic heterogeneity of the bile duct epithelium in alcoholic liver disease. VA Cooperative Study Group 275.
Chedid A; Mendenhall CL; Moritz TE
Arch Pathol Lab Med; 1999 May; 123(5):411-4. PubMed ID: 10235499
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
Sasaki M; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
[TBL] [Abstract][Full Text] [Related]
10. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
Broomé U; Hultcrantz R; Scheynius A
Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.
Barbatis C; Kelly P; Greveson J; Heryet A; McGee JO
J Clin Pathol; 1987 Aug; 40(8):879-84. PubMed ID: 3308964
[TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis (PBC): antigen-presenting cells differ in their distribution in early and late stage PBC and involve the ductal, but not the ductular compartment.
Rontogianni D; Gerber H; Zimmermann A
Histol Histopathol; 1994 Apr; 9(2):211-20. PubMed ID: 8075477
[TBL] [Abstract][Full Text] [Related]
13. Distribution of non-lymphoid, inflammatory cells in chronic HBV infection.
van den Oord JJ; De Vos R; Facchetti F; Delabie J; De Wolf-Peeters C; Desmet VJ
J Pathol; 1990 Mar; 160(3):223-30. PubMed ID: 2139889
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C.
Mosnier JF; Scoazec JY; Marcellin P; Degott C; Benhamou JP; Feldmann G
Gastroenterology; 1994 Nov; 107(5):1457-68. PubMed ID: 7523228
[TBL] [Abstract][Full Text] [Related]
15. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis.
Chapman RW; Kelly PM; Heryet A; Jewell DP; Fleming KA
Gut; 1988 Apr; 29(4):422-7. PubMed ID: 3286382
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.
Spengler U; Pape GR; Hoffmann RM; Johnson JP; Eisenburg J; Paumgartner G; Riethmüller G
Hepatology; 1988; 8(3):459-62. PubMed ID: 3371866
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.
Cruickshank SM; Southgate J; Wyatt JI; Selby PJ; Trejdosiewicz LK
J Clin Pathol; 1999 Oct; 52(10):730-4. PubMed ID: 10674028
[TBL] [Abstract][Full Text] [Related]
18. Morphologic features resembling transplant rejection in core biopsies of native livers from patients with Hepatitis C.
Souza P; Prihoda TJ; Hoyumpa AM; Sharkey FE
Hum Pathol; 2009 Jan; 40(1):92-7. PubMed ID: 18790517
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: an immunohistochemical study.
Nakanuma Y; Kono N
Hum Pathol; 1991 May; 22(5):431-6. PubMed ID: 2032692
[TBL] [Abstract][Full Text] [Related]
20. Hepatic overexpression of MHC class II antigens and macrophage-associated antigens (CD68) in patients with biliary atresia of poor prognosis.
Kobayashi H; Puri P; O'Briain DS; Surana R; Miyano T
J Pediatr Surg; 1997 Apr; 32(4):590-3. PubMed ID: 9126761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]